These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 17475821

  • 1. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.
    Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, Eichinger F, Gaiser S, Schmid H, Rastaldi MP, Schrier RW, Schlöndorff D, Cohen CD.
    J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821
    [Abstract] [Full Text] [Related]

  • 2. [Expression of VEGF in kidney of diabetic rats].
    Chen ZJ, Yang YB, Huang SM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428
    [Abstract] [Full Text] [Related]

  • 3. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor.
    Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, Shim SI, Suki WN, Truong LD.
    Hum Pathol; 2000 Dec; 31(12):1491-7. PubMed ID: 11150374
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
    Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH.
    J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586
    [Abstract] [Full Text] [Related]

  • 5. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V, Kulkarni O, Clauss S, Anders H-.
    Eur J Med Res; 2007 Aug 16; 12(8):351-5. PubMed ID: 17933712
    [Abstract] [Full Text] [Related]

  • 6. Role of peritubular capillaries and vascular endothelial growth factor in chronic allograft nephropathy.
    Modelli de Andrade LG, Viero RM, Carvalho MF.
    Transplant Proc; 2009 Nov 16; 41(9):3720-5. PubMed ID: 19917374
    [Abstract] [Full Text] [Related]

  • 7. Collagen type VIII expression in human diabetic nephropathy.
    Gerth J, Cohen CD, Hopfer U, Lindenmeyer MT, Sommer M, Gröne HJ, Wolf G.
    Eur J Clin Invest; 2007 Oct 16; 37(10):767-73. PubMed ID: 17888087
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis.
    Bosco MC, Delfino S, Ferlito F, Puppo M, Gregorio A, Gambini C, Gattorno M, Martini A, Varesio L.
    J Rheumatol; 2009 Jun 16; 36(6):1318-29. PubMed ID: 19369471
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic potential of angiostatin in diabetic nephropathy.
    Zhang SX, Wang JJ, Lu K, Mott R, Longeras R, Ma JX.
    J Am Soc Nephrol; 2006 Feb 16; 17(2):475-86. PubMed ID: 16394111
    [Abstract] [Full Text] [Related]

  • 13. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K, Zeier M, Gross ML, Waldherr R, Ritz E, Amann K.
    Nephrol Dial Transplant; 2006 May 16; 21(5):1365-72. PubMed ID: 16449275
    [Abstract] [Full Text] [Related]

  • 14. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug 16; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis.
    Paydas S, Balal M, Tanriverdi K, Sertdemir Y, Baslamisli F.
    Ren Fail; 2007 Aug 16; 29(7):779-84. PubMed ID: 17994443
    [Abstract] [Full Text] [Related]

  • 17. Endothelin-1 and endothelin a receptor immunoreactivity is increased in patients with diabetic nephropathy.
    Zanatta CM, Veronese FV, Loreto Mda S, Sortica DA, Carpio VN, Eldeweiss MI, da Silva VD, Lopes TG, Gross JL, Canani LH.
    Ren Fail; 2012 Aug 16; 34(3):308-15. PubMed ID: 22250646
    [Abstract] [Full Text] [Related]

  • 18. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN, Kozlovskaia LV, Rameeva AS, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2007 Aug 16; 79(6):10-5. PubMed ID: 17684960
    [Abstract] [Full Text] [Related]

  • 19. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE.
    Nephrol Dial Transplant; 2008 Apr 16; 23(4):1346-54. PubMed ID: 18065828
    [Abstract] [Full Text] [Related]

  • 20. Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy.
    Quattrini C, Jeziorska M, Boulton AJ, Malik RA.
    Diabetes Care; 2008 Jan 16; 31(1):140-5. PubMed ID: 17934147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.